Dr. Park doesn’t just enjoy helping people, but she also loves helping animals. She has rescued three dogs and finds joy in taking them for scenic walks. She also fosters dogs, which can be challenging but even more rewarding. She celebrates having many hobbies and passions, but she is the happiest when enjoying good food and doing anything with her family.
Minkyung Park, MD
Dr. Minkyung Park practices general adult psychiatry and finds purpose in helping her patients through a variety of cases such as adjustment disorder, depression, anxiety, bipolar disorder, schizophrenia, and PTSD. She has a particular interest in helping those with bipolar disorder and schizophrenia.
Available for Virtual Appointment
More about Minkyung Park, MD
Dr. Minkyung Park practices general adult psychiatry and finds purpose in helping her patients through a variety of cases such as adjustment disorder, depression, anxiety, bipolar disorder, schizophrenia, and PTSD. She has a particular interest in helping those with bipolar disorder and schizophrenia. Ultimately, she is fascinated by individual differences in how one understands and handles life’s challenges. Being a psychiatrist gives her the opportunity to learn about the endless possibilities of human experiences.
Dr. Park joined Mindful Health Solutions because of our evidence-based practice. She is excited to collaborate with other doctors on the team so they can expand their knowledge and grow professionally. She also joined us because we offer alternative treatment options, such as transcranial magnetic stimulation (TMS) therapy and esketamine nasal spray. Dr. Park is looking forward to offering noninvasive alternative treatment options for those who continue to suffer from treatment-resistant depression. She believes that these options provide hope for those who had minimal response to conventional therapy.
When first starting to work with a patient, Dr. Park likes to get to know them by gathering a thorough history. She works collaboratively with her patients by explaining her thought process and rationale. She also provides information so that patients can make informed and shared decisions in their treatment plans. Her goal is to give her patients individualized treatments and action steps to help them improve their lives in both small and profound ways.
Education & Experience
Dr. Minkyung Park began her medical career by earning her Doctor of Medicine from Jacob School of Medicine in Buffalo, New York. After earning her MD, she completed a psychiatry residency at Johns Hopkins. She then did a clinical research fellowship at the National Institute of Mental Health in Bethesda, Maryland conducting clinical trials for treatment-resistant depression. After completing her fellowship, she joined the University of Texas at Southwestern as an assistant professor. As an assistant professor, she worked in various settings such as an inpatient unit, community psychiatry, and a specialty clinic for early psychosis. She also mentored psychiatric residents, medical students, and PA students. Now, Dr. Park is joining us as a psychiatrist at our Houston clinic.
Certifications & Memberships
- Member, Psychiatric Hospital Patient Care Committee
- Member, Parkland Peer Review Committee
- Program Committee Member, American Society of Clinical Psychopharmacology
- Member, American Society of Clinical Psychopharmacology
- Past Member, Pharmacy and Therapeutics Committee
- Certified, SAMA
- Clinical Research Curriculum Certificate 2016
Park M, Newman LE, et. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression, J Psychiatr Res 2017 Jan: 113-118
Kadriu B, Yuan S, Farmer C, Nugent AC, Lener MS, Niciu MJ, Park M, et Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability, J Clin Psychopharmacol 2018 Jun;38(3): 243-246
Park M, Niciu MJ, Zarate CA Jr. Novel Glutamatergic Treatments for Severe Mood Disorders, Current Behav Neurosci Rep. 2015 Dec; 2(4): 198-208
Niciu MJ, Iadarola ND, Banerjee D, Luckenbaugh DA, Park M et. The antidepressant efficacy of subanesthetic-dose ketamine dose does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder, J Psychopharmacol. 2017 Dec;31(12): 1570-1577
Lener MS, Niciu MJ, Ballard ED, Park M et. Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine, Bio Psychiatry 2016 May
Jaso BA, Niciu MJ, Iadarola ND, Lally N, Richards EM, Park M et. Therapeutic Modulation of Glutamate Receptors In Major Depressive Disorder, Current Neuropharmacology 2015 March